Ridloff Elena sold KYMR
April 1, 2026 · Form 4 insider transaction
Ridloff Elena sold 1,200 shares of Kymera Therapeutics, Inc. at $86.05 per share, a transaction worth $103.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,200
Price
$86.05
Total value
$103.3K
InsiderRidloff Elena
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 1, 2026
Filing dateApril 1, 2026
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 11, 2025 adopted by the reporting person.